On the dark side of therapies with immunoglobulin concentrates. The adverse events

On the dark side of therapies with immunoglobulin concentrates. The adverse events

Abstract to the dark side of therapies with human immunoglobulin G concentratesTherapy by human immunoglobulin G (IgG) concentrates is a success story ongoing for decades with an ever increasing demand for this plasma product. The success of IgG concentrates on a clinical level is documented by the...

Full description

Bibliographic Details
Main Authors: Peter J. Spaeth, Guido eGranata, Fabiola eLa Marra, Taco W. Kuijpers, Isabella eQuinti
Format: Article
Language:English
Published: Frontiers Media S.A. 2015-02-01
Series:Frontiers in Immunology
Subjects:
Hemolysis
Thrombosis
adverse events
IVIg
comp
SCIG
Online Access:http://journal.frontiersin.org/Journal/10.3389/fimmu.2015.00011/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fimmu.2015.00011/full

Similar Items